This randomized clinical trial compares the efficacy of a treat-to-target low-density lipoprotein cholesterol (LDL-C) strategy of 50 to 70 mg/dL as the goal vs
A recently published study by FMI expects the global arterial cannula market to augment at a 6.6% CAGR from 2022 to 2032. By the end of the said assessment period, a valuation of US$ 40 Billion is expected for the market. The rising frequency of chronic diseases necessitating cardiopulmonary bypass surgery (CABG), d...
/PRNewswire/ -- The patient monitoring devices market size reached USD 47 Billion in 2021 and is expected to register a CAGR of 7.8% during the forecast...
/PRNewswire/ -- The patient monitoring devices market size reached USD 47 Billion in 2021 and is expected to register a CAGR of 7.8% during the forecast...
Patient Monitoring Devices Market Size to Reach USD 92.40 Billion in 2030 finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
PAVmed is a commercial-stage, diversified medical technology company operating in three segments:. the device space, the diagnostic space, and in digital health.
Arterial Cannula Market is set Breach a Revenue of US$ 21 Bn in 2023 & is Further Estimated to Cross worth of US$ 40 Bn by Clocking a CAGR of 6.6% During Forecast Period 2023-33 – Future Market Insights, Inc. forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Chronus' grant program spotlights the impact of educational and professional mentoring for underrepresented groupsSEATTLE, WA / ACCESSWIRE / November 10, 2022 / Chronus, the leading enterprise mentoring